It's Settled: A Federal Judge Approves A Nationwide Payout For Purdue Pharma – The Motley Fool

0
175

Returns as of 03/10/2022
Returns as of 03/10/2022
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new every day.
Purdue Pharma first introduced its signature painkiller OxyContin to the market in 1996, and experts have since painted the company as one of the chief culprits of an ensuing opioid epidemic that has been linked to the deaths of over 500,000 Americans in the last two decades.
On Wednesday, the Purdue-owning Sackler family came one step closer to facing justice when a federal bankruptcy judge approved a nationwide settlement that will transform the company into a public trust and pay out billions of dollars to its victims and their families.
Purdue first filed for bankruptcy in 2019 amid thousands of lawsuits, headlined by a suit led by attorney generals from 20 states and the District of Columbia. That case initially came to a settlement last September, but eight states and DC successfully appealed by arguing the Sacklers were not appropriately held accountable.
Under the new agreement, the family will be paying out billions more:
Civil vs. Criminal: Part of the settlement does give the Sacklers immunity from future civil suits, but not criminal charges. Already, seven US senators have requested the Department of Justice consider charges.
Industry Standard: Johnson & Johnson, as well as wholesalers AmerisourceBergen, Cardinal Health, and McKesson, settled a lawsuit in February over their own role in the opioid crisis; the companies will send $26 billion to nearly every state and local government in the US.

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool’s premium services.

Making the world smarter, happier, and richer.

Market data powered by Xignite.

source